Stage IV Adrenocortical Carcinoma Active Not Recruiting Phase 3 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0028759 (Stage IV Adrenocortical Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs